10-71803030-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_022124.6(CDH23):c.7615G>C(p.Gly2539Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.7615G>C | p.Gly2539Arg | missense_variant | Exon 54 of 70 | ENST00000224721.12 | NP_071407.4 | |
CDH23 | NM_001171933.1 | c.895G>C | p.Gly299Arg | missense_variant | Exon 7 of 23 | NP_001165404.1 | ||
CDH23 | NM_001171934.1 | c.895G>C | p.Gly299Arg | missense_variant | Exon 7 of 22 | NP_001165405.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152220Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249116Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135140
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461612Hom.: 0 Cov.: 38 AF XY: 0.0000234 AC XY: 17AN XY: 727076
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152220Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Gly2539Arg variant in CDH23 has not been reported in the literature nor prev iously identified by our laboratory. This variant has been identified in 1/8346 (0.01%) European American chromosomes from a broad, though clinically unspecifie d population (NHLBI Exome Sequencing Project; http://evs.gs.washington.edu/EVS). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational analyses (biochemi cal amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Gly2539Arg variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, additional data is needed to determine the clinical significance of this variant. -
Inborn genetic diseases Uncertain:1
The c.7615G>C (p.G2539R) alteration is located in exon 54 (coding exon 53) of the CDH23 gene. This alteration results from a G to C substitution at nucleotide position 7615, causing the glycine (G) at amino acid position 2539 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Usher syndrome type 1 Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces glycine with arginine at codon 2539 of the CDH23 protein (p.Gly2539Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs373649718, ExAC 0.009%). This variant has not been reported in the literature in individuals with CDH23-related conditions. ClinVar contains an entry for this variant (Variation ID: 46035). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at